Coegin Pharma is a Swedish biotech company with groundbreaking projects in hair growth, myocardial infarction, leukemia, and skin cancer.

Our business idea is to develop products in attractive areas where treatments are lacking, there is significant commercial value, and an opportunity for early exit.

ABOUT US

Our research

In our total project portfolio, we currently have five projects: four drug candidates and a product series in dermacosmetics. What the projects have in common is that they are based on two unique validated technology platforms resting on solid research and collaborations with pioneering and internationally recognized researchers and academics.

Latest news

Press releases

More press releases

Reports

More reports

Upcoming events

More events

Video presentations

See more

Team Coegin

Our management team has extensive experience in drug development, commercialization and business scale-up.

Meet the team
Jens Eriksson

CEO

Lars Bukhave Rasmussen

CFO

John Zibert

CMO